O35.8

Clinical Causes: Maternal listeriosis, an infection caused by the bacteria Listeria monocytogenes, which can cross the placental barrier and harm the fetus. Maternal toxoplasmosis, an infection due to the parasite Toxoplasma gondii, which can lead to fetal damage if contracted during pregnancy. Other maternal infections that may impact fetal development, although the primary concerns with this code focus on listeriosis and toxoplasmosis.

Key Symptoms: Maternal symptoms may be mild or absent but can include flu-like symptoms such as fever, muscle aches, or fatigue. Signs of potential fetal distress may include reduced fetal movement or abnormal ultrasound findings. Specific indications of fetal abnormalities, which could be detected through prenatal testing, such as ventriculomegaly, growth restrictions, or structural anomalies.

Diagnosis Path: Diagnosis involves a combination of maternal medical history, blood tests to identify infections like listeriosis and toxoplasmosis, and imaging studies such as ultrasound to assess fetal development. Amniocentesis might be performed in some cases to test amniotic fluid for infectious agents or genetic material. Regular prenatal check-ups facilitate early detection of fetal abnormalities suspected to be caused by maternal infections.

Treatment Protocols: Treatment depends on the specific infection and the gestational stage. Antibiotic therapy, such as penicillin for listeriosis or specific anti-parasitic medications for toxoplasmosis, may be administered to the mother to reduce the risk of transmission and fetal damage. Close fetal monitoring through ultrasound, non-stress tests, and other assessments is essential. In some instances, the healthcare provider may recommend early delivery if fetal health is compromised. Supportive care and counseling are also integral parts of managing these cases.